SCHEMBL1129900

SCHEMBL1129900

O[C](Cc1ccc(Cl)cc1)c1ccccc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 4/20 0.55
MAPT P10636 1/20 0.55
MEN1 O00255 3/20 0.50
KMT2A Q03164 3/20 0.50
ALDH1A1 P00352 2/20 0.50
POLB P06746 2/20 0.50
HPGD P15428 1/20 0.50
TDP1 Q9NUW8 1/20 0.49
CES2 O00748 1/20 0.48
CES1 P23141 1/20 0.48
EGFR P00533 1/20 0.45
ERBB2 P04626 1/20 0.45
PDPK1 O15530 1/20 0.45
NPC1 O15118 2/20 0.44
RAB9A P51151 2/20 0.44
CTBP2 P56545 1/20 0.44
SIGMAR1 Q99720 1/20 0.44
CNR2 P34972 2/20 0.42
GFER P55789 1/20 0.42
ATM Q13315 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2322710 0.84 CES1 (0.52) L3MBTL1MAPTMEN1KMT2AALDH1A1
SCHEMBL6309158 0.79 L3MBTL1 (0.52) L3MBTL1MAPTMEN1KMT2AALDH1A1
SCHEMBL2448732 0.79 L3MBTL1 (0.52) L3MBTL1MAPTMEN1KMT2AALDH1A1
SCHEMBL4066362 0.79 L3MBTL1 (0.52) L3MBTL1MAPTMEN1KMT2AALDH1A1
SCHEMBL571046 0.79 L3MBTL1 (0.85) L3MBTL1MAPTMEN1KMT2AALDH1A1
SCHEMBL9147717 0.75 ALDH1A1 (0.48) L3MBTL1MAPTMEN1KMT2AALDH1A1
SCHEMBL5680205 0.75 L3MBTL1 (0.57) L3MBTL1MAPTMEN1KMT2AALDH1A1
SCHEMBL8406795 0.74 L3MBTL1 (0.66) L3MBTL1MAPTMEN1KMT2AALDH1A1
SCHEMBL7767316 0.74 L3MBTL1 (0.66) L3MBTL1MAPTMEN1KMT2AALDH1A1
SCHEMBL19936252 0.72 L3MBTL1 (0.45) L3MBTL1MAPTMEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2282753-A1 ASSAY FOR PATHOGENIC CONFORMERS Novartis AG (CH) 2011-02-16 EP disclosed
WO-2009134942-A1 ASSAY FOR PATHOGENIC CONFORMERS NOVARTIS AG. (CH) 2009-11-05 WO disclosed